Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ardelyx, Inc. (ARDX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ardelyx, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1437402.
Total stock buying since 2015: $685,392,043.
Total stock sales since 2015: $43,231,513.
Total stock option exercises since 2015: $2,014,301.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,158,106 | $4,784,370 | 494,727 | $2,584,188 | 254,166 | $207,621 |
| 2024 | 215,868 | $996,662 | 1,505,564 | $11,147,369 | 693,888 | $1,224,644 |
| 2023 | 0 | $0 | 539,979 | $2,731,579 | 108,333 | $188,248 |
| 2022 | 2,889,000 | $5,037,201 | 629,644 | $566,452 | 0 | $0 |
| 2021 | 0 | $0 | 5,890,134 | $7,577,251 | 285,392 | $154,111 |
| 2020 | 315,644 | $1,998,216 | 680,999 | $4,289,107 | 78,123 | $136,452 |
| 2019 | 66 | $495 | 97,167 | $295,257 | 30,000 | $45,000 |
| 2018 | 10,000 | $40,000 | 25,779 | $73,294 | 0 | $0 |
| 2017 | 0 | $0 | 26,700 | $263,494 | 6,000 | $3,240 |
| 2016 | 39,188,162 | $361,783,231 | 27,045 | $335,943 | 21,000 | $20,905 |
| 2015 | 29,033,691 | $310,751,868 | 554,269 | $13,367,579 | 51,727 | $34,080 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 165,551 | $997,166 | 50,000 | $49,500 |
| 2025-06 | 400,000 | $1,463,000 | 0 | $0 | 0 | $0 |
| 2025-05 | 481,377 | $1,940,036 | 125,143 | $517,831 | 20,833 | $20,624 |
| 2025-04 | 0 | $0 | 41,666 | $191,163 | 20,833 | $20,624 |
| 2025-03 | 0 | $0 | 41,668 | $223,215 | 20,834 | $20,625 |
| 2025-02 | 77,729 | $388,722 | 37,367 | $210,113 | 0 | $0 |
| 2025-01 | 199,000 | $992,612 | 83,332 | $444,700 | 141,666 | $96,248 |
| 2024-12 | 0 | $0 | 25,000 | $131,625 | 25,000 | $24,750 |
| 2024-11 | 215,868 | $996,662 | 145,863 | $781,139 | 54,343 | $126,075 |
| 2024-10 | 0 | $0 | 32,500 | $192,825 | 25,000 | $24,750 |
| 2024-09 | 0 | $0 | 92,876 | $590,830 | 35,000 | $34,650 |
| 2024-08 | 0 | $0 | 124,225 | $734,866 | 20,507 | $20,301 |
| 2024-07 | 0 | $0 | 37,500 | $214,087 | 30,000 | $29,700 |
| 2024-06 | 0 | $0 | 238,182 | $1,632,346 | 135,000 | $309,650 |
| 2024-05 | 0 | $0 | 574,772 | $5,043,996 | 339,038 | $625,068 |
| 2024-04 | 0 | $0 | 39,018 | $256,083 | 30,000 | $29,700 |
| 2024-03 | 0 | $0 | 86,000 | $664,952 | 0 | $0 |
| 2024-02 | 0 | $0 | 79,628 | $705,420 | 0 | $0 |
| 2024-01 | 0 | $0 | 30,000 | $199,200 | 0 | $0 |
| 2023-12 | 0 | $0 | 317,947 | $1,914,187 | 75,000 | $74,250 |
| 2023-11 | 0 | $0 | 59,566 | $251,188 | 0 | $0 |
| 2023-10 | 0 | $0 | 1,644 | $6,576 | 0 | $0 |
| 2023-09 | 0 | $0 | 2,897 | $13,181 | 0 | $0 |
| 2023-08 | 0 | $0 | 31,696 | $112,580 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | Williams Laura A (Chief Patient Officer) | Sale | 80,000 | 6.12 | 489,680 |
| 2025-08-26 | Williams Laura A (Chief Patient Officer) | Option Ex | 50,000 | .99 | 49,500 |
| 2025-08-21 | Foster Eric Duane (Chief Commercial Officer) | Sale | 15,308 | 5.93 | 90,807 |
| 2025-08-21 | Kelliher Mike (Chief Business Officer) | Sale | 5,417 | 5.93 | 32,133 |
| 2025-08-21 | Williams Laura A (Chief Patient Officer) | Sale | 6,261 | 5.93 | 37,140 |
| 2025-08-21 | Renz Justin A (Chief Financial Officer) | Sale | 7,037 | 5.93 | 41,743 |
| 2025-08-21 | Raab Michael (President & CEO) | Sale | 45,687 | 5.93 | 271,015 |
| 2025-08-21 | Grammer Elizabeth A (See Remarks) | Sale | 5,841 | 5.93 | 34,648 |
| 2025-06-16 | Mott David M | Buy | 200,000 | 3.63 | 725,800 |
| 2025-06-09 | Mott David M | Buy | 200,000 | 3.69 | 737,200 |
| 2025-05-20 | Foster Eric Duane (Chief Commercial Officer) | Sale | 2,507 | 4.08 | 10,231 |
| 2025-05-20 | Kelliher Mike (See Remarks) | Sale | 14,522 | 4.08 | 59,264 |
| 2025-05-20 | Williams Laura A (Chief Medical Officer) | Sale | 6,421 | 4.08 | 26,204 |
| 2025-05-20 | Renz Justin A (Chief Financial Officer) | Sale | 7,218 | 4.08 | 29,456 |
| 2025-05-20 | Raab Michael (President & CEO) | Sale | 46,817 | 4.08 | 191,060 |
| 2025-05-20 | Grammer Elizabeth A (See Remarks) | Sale | 5,992 | 4.08 | 24,453 |
| 2025-05-15 | Mott David M | Buy | 100,000 | 3.29 | 329,100 |
| 2025-05-02 | Raab Michael (President & CEO) | Sale | 41,666 | 4.25 | 177,163 |
| 2025-05-02 | Raab Michael (President & CEO) | Option Ex | 20,833 | .99 | 20,624 |
| 2025-05-02 | Mott David M | Buy | 381,377 | 4.22 | 1,610,936 |
| 2025-04-04 | Raab Michael (President & CEO) | Sale | 41,666 | 4.59 | 191,163 |
| 2025-04-04 | Raab Michael (President & CEO) | Option Ex | 20,833 | .99 | 20,624 |
| 2025-03-07 | Raab Michael (President & CEO) | Sale | 41,668 | 5.36 | 223,215 |
| 2025-03-07 | Raab Michael (President & CEO) | Option Ex | 20,834 | .99 | 20,625 |
| 2025-02-24 | Mott David M | Buy | 77,729 | 5.00 | 388,722 |
| 2025-02-20 | Williams Laura A (Chief Medical Officer) | Sale | 4,941 | 5.62 | 27,783 |
| 2025-02-20 | Renz Justin A (Chief Financial Officer) | Sale | 5,171 | 5.62 | 29,076 |
| 2025-02-20 | Raab Michael (President & CEO) | Sale | 22,964 | 5.62 | 129,126 |
| 2025-02-20 | Grammer Elizabeth A (See Remarks) | Sale | 4,291 | 5.62 | 24,128 |
| 2025-01-31 | Raab Michael (President & CEO) | Sale | 41,666 | 5.36 | 223,371 |
| 2025-01-31 | Raab Michael (President & CEO) | Option Ex | 20,833 | .99 | 20,624 |
| 2025-01-21 | Mott David M | Buy | 199,000 | 4.99 | 992,612 |
| 2025-01-16 | Rodgers Richard J | Option Ex | 100,000 | .55 | 55,000 |
| 2025-01-07 | Raab Michael (President & CEO) | Sale | 41,666 | 5.31 | 221,329 |
| 2025-01-07 | Raab Michael (President & CEO) | Option Ex | 20,833 | .99 | 20,624 |
| 2024-12-10 | Raab Michael (President & CEO) | Sale | 25,000 | 5.26 | 131,625 |
| 2024-12-10 | Raab Michael (President & CEO) | Option Ex | 25,000 | .99 | 24,750 |
| 2024-11-25 | Raab Michael (President & CEO) | Sale | 25,000 | 5.38 | 134,475 |
| 2024-11-20 | Williams Laura A (Chief Medical Officer) | Sale | 7,366 | 4.79 | 35,319 |
| 2024-11-20 | Blanks Robert (See Remarks) | Sale | 4,941 | 4.79 | 23,692 |
| 2024-11-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 7,184 | 4.79 | 34,447 |
| 2024-11-20 | Renz Justin A (Chief Financial Officer) | Sale | 5,260 | 4.79 | 25,221 |
| 2024-11-20 | Raab Michael (President & CEO) | Sale | 31,980 | 4.79 | 153,344 |
| 2024-11-20 | Grammer Elizabeth A (See Remarks) | Sale | 7,046 | 4.79 | 33,785 |
| 2024-11-13 | Mott David M | Buy | 215,868 | 4.62 | 996,662 |
| 2024-11-11 | Raab Michael (President & CEO) | Sale | 2,743 | 4.90 | 13,440 |
| 2024-11-06 | Rosenbaum David P. (Chief Development Officer) | Sale | 27,171 | 6.10 | 165,743 |
| 2024-11-06 | Rosenbaum David P. (Chief Development Officer) | Option Ex | 27,171 | 2.32 | 63,036 |
| 2024-11-04 | Rosenbaum David P. (Chief Development Officer) | Sale | 27,172 | 5.95 | 161,673 |
| 2024-11-04 | Rosenbaum David P. (Chief Development Officer) | Option Ex | 27,172 | 2.32 | 63,039 |
| 2024-10-28 | Raab Michael (President & CEO) | Sale | 25,000 | 5.91 | 147,750 |
| 2024-10-28 | Raab Michael (President & CEO) | Option Ex | 25,000 | .99 | 24,750 |
| 2024-10-11 | Raab Michael (President & CEO) | Sale | 7,500 | 6.01 | 45,075 |
| 2024-09-27 | Rosenbaum David P. (Chief Development Officer) | Sale | 49,564 | 6.92 | 342,982 |
| 2024-09-26 | Raab Michael (President & CEO) | Sale | 3,000 | 6.07 | 18,210 |
| 2024-09-13 | Rosenbaum David P. (Chief Development Officer) | Sale | 5,312 | 6.26 | 33,253 |
| 2024-09-11 | Raab Michael (President & CEO) | Sale | 35,000 | 5.61 | 196,385 |
| 2024-09-11 | Raab Michael (President & CEO) | Option Ex | 35,000 | .99 | 34,650 |
| 2024-08-27 | Raab Michael (President & CEO) | Sale | 7,500 | 6.22 | 46,635 |
| 2024-08-20 | Felsch Robert Ora (See Remarks) | Sale | 3,567 | 5.86 | 20,902 |
| 2024-08-20 | Williams Laura A (Chief Medical Officer) | Sale | 7,412 | 5.86 | 43,434 |
| 2024-08-20 | Blanks Robert (See Remarks) | Sale | 4,969 | 5.86 | 29,118 |
| 2024-08-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 27,726 | 5.93 | 165,345 |
| 2024-08-20 | Rosenbaum David P. (Chief Development Officer) | Option Ex | 20,507 | .99 | 20,301 |
| 2024-08-20 | Renz Justin A (Chief Financial Officer) | Sale | 5,289 | 5.86 | 30,993 |
| 2024-08-20 | Raab Michael (President & CEO) | Sale | 32,225 | 5.86 | 188,838 |
| 2024-08-20 | Grammer Elizabeth A (See Remarks) | Sale | 7,089 | 5.86 | 41,541 |
| 2024-08-16 | Rosenbaum David P. (Chief Development Officer) | Sale | 20,000 | 5.94 | 118,740 |
| 2024-08-12 | Raab Michael (President & CEO) | Sale | 1,229 | 5.71 | 7,017 |
| 2024-07-29 | Raab Michael (President & CEO) | Sale | 30,000 | 5.64 | 169,320 |
| 2024-07-29 | Raab Michael (President & CEO) | Option Ex | 30,000 | .99 | 29,700 |
| 2024-07-15 | Raab Michael (President & CEO) | Sale | 7,500 | 5.97 | 44,767 |
| 2024-06-28 | Raab Michael (President & CEO) | Sale | 2,310 | 6.59 | 15,222 |
| 2024-06-21 | Blanks Robert (See Remarks) | Sale | 38,000 | 5.96 | 226,290 |
| 2024-06-13 | Raab Michael (President & CEO) | Sale | 35,000 | 6.65 | 232,750 |
| 2024-06-13 | Raab Michael (President & CEO) | Option Ex | 35,000 | .99 | 34,650 |
| 2024-06-05 | Williams Laura A (Chief Medical Officer) | Sale | 145,000 | 7.12 | 1,032,980 |
| 2024-06-05 | Williams Laura A (Chief Medical Officer) | Option Ex | 100,000 | 2.75 | 275,000 |
| 2024-06-03 | Rosenbaum David P. (Chief Development Officer) | Sale | 17,872 | 7.00 | 125,104 |
| 2024-05-29 | Raab Michael (President & CEO) | Sale | 7,500 | 6.72 | 50,392 |
| 2024-05-21 | Felsch Robert Ora (See Remarks) | Sale | 3,485 | 7.81 | 27,221 |
| 2024-05-21 | Williams Laura A (Chief Medical Officer) | Sale | 4,794 | 7.81 | 37,445 |
| 2024-05-21 | Blanks Robert (See Remarks) | Sale | 4,855 | 7.81 | 37,922 |
| 2024-05-21 | Rosenbaum David P. (Chief Development Officer) | Sale | 7,053 | 7.81 | 55,090 |
| 2024-05-21 | Grammer Elizabeth A (See Remarks) | Sale | 6,927 | 7.81 | 54,106 |
| 2024-05-14 | Raab Michael (President & CEO) | Sale | 3,000 | 7.99 | 23,970 |
| 2024-05-06 | Felsch Robert Ora (See Remarks) | Sale | 207,988 | 8.80 | 1,831,126 |
| 2024-05-06 | Felsch Robert Ora (See Remarks) | Option Ex | 119,101 | 1.79 | 213,786 |
| 2024-05-06 | Grammer Elizabeth A (See Remarks) | Sale | 284,170 | 8.87 | 2,521,724 |
| 2024-05-06 | Grammer Elizabeth A (See Remarks) | Option Ex | 219,937 | 1.87 | 411,282 |
| 2024-05-03 | Grammer Elizabeth A (See Remarks) | Sale | 45,000 | 9.00 | 405,000 |
| 2024-04-29 | Raab Michael (President & CEO) | Sale | 30,000 | 6.40 | 192,060 |
| 2024-04-29 | Raab Michael (President & CEO) | Option Ex | 30,000 | .99 | 29,700 |
| 2024-04-15 | Raab Michael (President & CEO) | Sale | 7,500 | 7.06 | 52,927 |
| 2024-04-01 | Raab Michael (President & CEO) | Sale | 1,518 | 7.31 | 11,096 |
| 2024-03-20 | Grammer Elizabeth A (See Remarks) | Sale | 86,000 | 7.73 | 664,952 |
| 2024-02-26 | Rosenbaum David P. (Chief Development Officer) | Sale | 5,183 | 9.20 | 47,683 |
| 2024-02-20 | Felsch Robert Ora (See Remarks) | Sale | 2,352 | 8.75 | 20,570 |
| 2024-02-20 | Williams Laura A (Chief Medical Officer) | Sale | 4,803 | 8.75 | 42,007 |
| 2024-02-20 | Blanks Robert (See Remarks) | Sale | 5,017 | 8.75 | 43,878 |
| 2024-02-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 6,928 | 8.75 | 60,592 |
| 2024-02-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 7,311 | 8.75 | 63,942 |
| 2024-02-20 | Renz Justin A (Chief Financial Officer) | Sale | 5,341 | 8.75 | 46,712 |
| 2024-02-20 | Raab Michael (President & CEO) | Sale | 22,917 | 8.75 | 200,432 |
| 2024-02-20 | Grammer Elizabeth A (See Remarks) | Sale | 4,432 | 8.75 | 38,762 |
| 2024-02-08 | Rosenbaum David P. (Chief Development Officer) | Sale | 15,344 | 9.18 | 140,842 |
| 2024-01-08 | Rosenbaum David P. (Chief Development Officer) | Sale | 30,000 | 6.64 | 199,200 |
| 2023-12-26 | Renz Justin A (Chief Financial Officer) | Sale | 225,000 | 6.36 | 1,430,100 |
| 2023-12-26 | Renz Justin A (Chief Financial Officer) | Option Ex | 75,000 | .99 | 74,250 |
| 2023-12-18 | Rosenbaum David P. (Chief Development Officer) | Sale | 5,675 | 6.07 | 34,447 |
| 2023-12-14 | Rosenbaum David P. (Chief Development Officer) | Sale | 7,000 | 5.55 | 38,850 |
| 2023-12-11 | Grammer Elizabeth A (See Remarks) | Sale | 50,000 | 5.08 | 253,950 |
| 2023-12-08 | Rosenbaum David P. (Chief Development Officer) | Sale | 20,000 | 5.27 | 105,480 |
| 2023-12-05 | Rosenbaum David P. (Chief Development Officer) | Sale | 10,272 | 5.00 | 51,360 |
| 2023-11-30 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,000 | 4.50 | 13,500 |
| 2023-11-20 | Felsch Robert Ora (See Remarks) | Sale | 1,044 | 4.36 | 4,553 |
| 2023-11-20 | Williams Laura A (Chief Medical Officer) | Sale | 2,581 | 4.36 | 11,258 |
| 2023-11-20 | Blanks Robert (See Remarks) | Sale | 2,835 | 4.36 | 12,366 |
| 2023-11-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 4,714 | 4.36 | 20,562 |
| 2023-11-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,767 | 4.36 | 16,431 |
| 2023-11-20 | Renz Justin A (Chief Financial Officer) | Sale | 2,873 | 4.36 | 12,532 |
| 2023-11-20 | Raab Michael (President & CEO) | Sale | 11,368 | 4.36 | 49,587 |
| 2023-11-20 | Grammer Elizabeth A (See Remarks) | Sale | 2,384 | 4.36 | 10,399 |
| 2023-11-15 | Williams Laura A (Chief Medical Officer) | Sale | 25,000 | 4.00 | 100,000 |
| 2023-10-10 | Rosenbaum David P. (Chief Development Officer) | Sale | 1,644 | 4.00 | 6,576 |
| 2023-09-08 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,897 | 4.55 | 13,181 |
| 2023-08-21 | Felsch Robert Ora (See Remarks) | Sale | 1,048 | 3.55 | 3,722 |
| 2023-08-21 | Williams Laura A (Chief Medical Officer) | Sale | 2,591 | 3.55 | 9,203 |
| 2023-08-21 | Blanks Robert (See Remarks) | Sale | 2,846 | 3.55 | 10,108 |
| 2023-08-21 | Rodriguez Susan (Chief Commercial Officer) | Sale | 4,733 | 3.55 | 16,811 |
| 2023-08-21 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,783 | 3.55 | 13,437 |
| 2023-08-21 | Renz Justin A (Chief Financial Officer) | Sale | 2,884 | 3.55 | 10,243 |
| 2023-08-21 | Raab Michael (President & CEO) | Sale | 11,419 | 3.55 | 40,560 |
| 2023-08-21 | Grammer Elizabeth A (See Remarks) | Sale | 2,392 | 3.55 | 8,496 |
| 2023-06-27 | Williams Laura A (Chief Medical Officer) | Sale | 25,000 | 3.35 | 83,625 |
| 2023-06-23 | Blanks Robert (See Remarks) | Sale | 33,333 | 3.63 | 121,032 |
| 2023-06-23 | Blanks Robert (See Remarks) | Option Ex | 33,333 | 3.42 | 113,998 |
| 2023-05-23 | Felsch Robert Ora (See Remarks) | Sale | 1,046 | 3.65 | 3,821 |
| 2023-05-23 | Williams Laura A (Chief Medical Officer) | Sale | 2,583 | 3.65 | 9,435 |
| 2023-05-23 | Blanks Robert (See Remarks) | Sale | 2,835 | 3.65 | 10,356 |
| 2023-05-23 | Rodriguez Susan (Chief Commercial Officer) | Sale | 4,711 | 3.65 | 17,209 |
| 2023-05-23 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,769 | 3.65 | 13,768 |
| 2023-05-23 | Renz Justin A (Chief Financial Officer) | Sale | 2,873 | 3.65 | 10,495 |
| 2023-05-23 | Raab Michael (President & CEO) | Sale | 11,357 | 3.65 | 41,487 |
| 2023-05-23 | Grammer Elizabeth A (See Remarks) | Sale | 2,384 | 3.65 | 8,708 |
| 2023-03-29 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,000 | 4.63 | 13,886 |
| 2023-02-21 | Felsch Robert Ora (See Remarks) | Sale | 3,214 | 3.00 | 9,645 |
| 2023-02-21 | Williams Laura A (Chief Medical Officer) | Sale | 3,187 | 3.00 | 9,564 |
| 2023-02-21 | Blanks Robert (See Remarks) | Sale | 3,394 | 3.00 | 10,185 |
| 2023-02-21 | Rodriguez Susan (Chief Commercial Officer) | Sale | 5,586 | 3.00 | 16,763 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ardelyx, Inc. (symbol ARDX, CIK number 1437402) see the Securities and Exchange Commission (SEC) website.